# Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study

> **NCT00853541** · — · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00853541
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-03
- **Primary completion:** 2010-10
- **Final completion:** 2011-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients enrolled.
- **Last updated:** 2015-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00853541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00853541, "Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00853541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*